RT Journal Article
SR Electronic
T1 Baclofen Inhibits Heroin Self-Administration Behavior and Mesolimbic Dopamine Release
JF Journal of Pharmacology and Experimental Therapeutics
JO J Pharmacol Exp Ther
FD American Society for Pharmacology and Experimental Therapeutics
SP 1369
OP 1374
VO 290
IS 3
A1 Xi, Zheng-Xiong
A1 Stein, Elliot A.
YR 1999
UL http://jpet.aspetjournals.org/content/290/3/1369.abstract
AB An emerging hypothesis to explain the mechanism of heroin-induced positive reinforcement states that opiates inhibit γ-aminobutyric acid (GABA)-ergic interneurons within the mesocorticolimbic dopamine (DA) system to disinhibit DA neurons. In support of this hypothesis, we report that the development of heroin self-administration (SA) behavior in drug-naive rats and the maintenance of SA behavior in heroin-trained rats were both suppressed when the GABAB receptor agonist baclofen was coadministered with heroin. Microinjections of baclofen into the ventral tegmental area (VTA), but not the nucleus accumbens, decreased heroin reinforcement as indicated by a compensatory increase in SA behavior. Additionally, baclofen administered alone or along with heroin dose-dependently reduced heroin-induced DA release. This effect was blocked partially by intra-VTA infusion of the GABABantagonist 2-hydroxysaclofen, suggesting an additional, perhaps GABAA receptor-mediated, disinhibitory effect. Taken together, these experiments, for the first time, demonstrate that heroin-reinforced SA behavior and nucleus accumbens DA release are mediated predominantly by GABAB receptors in the VTA and suggest that baclofen may be an effective agent in the treatment of opiate abuse. The American Society for Pharmacology and Experimental Therapeutics